Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Status:
Completed
Trial end date:
2019-06-20
Target enrollment:
Participant gender:
Summary
In this study, investigators will conduct a phase I/II trial in recurrent (temozolomide
resistant) glioma patients. The overall goal of this study is to provide a foundation for
future studies with indoximod tested in newly diagnosed glioblastoma patients with radiation
and temozolomide, or in combination with vaccine therapies.